Using special peptides to speed up healing of pressure ulcers
Regenerative peptide therapy to accelerate pressure ulcer healing
This study is testing a special gel that helps heal bed sores by improving blood flow and tissue repair, and it's being tried out on older diabetic mice to see how well it works compared to a current approved treatment.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Adepthera, LLC NIH-funded |
| Lab location | 1 site (Palo Alto, United States) |
| Project ID | NIH-11006211 on NIH RePORTER |
What this research studies
This research investigates the use of super-agonistic analogs of adrenomedullin (ADM) and calcitonin gene-related peptide (CGRP) to enhance the healing of pressure ulcers, also known as bed sores. The approach involves creating a gel that self-assembles at the wound site, allowing for localized treatment that improves blood circulation and promotes tissue regeneration. The therapy is designed to be administered weekly or biweekly, targeting aging diabetic mice to determine the most effective formulation and dosage. The study aims to compare the effectiveness of this new gel with an existing FDA-approved treatment for wound care.
Who could benefit from this research
Good fit: Ideal candidates for this research are elderly patients or those with diabetes who are at risk of developing pressure ulcers.
Not a fit: Patients who do not have pressure ulcers or those with acute wounds may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new treatment that significantly accelerates the healing of pressure ulcers in patients.
How similar studies have performed: Previous research has shown promise with similar peptide therapies in enhancing wound healing, indicating potential for success in this approach.
Where this research is happening
Palo Alto, United States
- Adepthera, LLC — Palo Alto, United States (Active)
Researchers
- Principal investigator: Hsu, Sheau-Yu Teddy — Adepthera, LLC
- Study coordinator: Hsu, Sheau-Yu Teddy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.